116 related articles for article (PubMed ID: 23069307)
1. Pharmacological treatment in patients with chronic venous disease.
Marinović Kulišić S; Lupi D
Acta Dermatovenerol Croat; 2012; 20(3):197-200. PubMed ID: 23069307
[No Abstract] [Full Text] [Related]
2. [Current aspects of drug correction of impaired circulation in the ocular vessels].
Kiseleva TN; Polunin GS; Lagutina IuM
Vestn Oftalmol; 2007; 123(2):37-9. PubMed ID: 17650609
[No Abstract] [Full Text] [Related]
3. Iloprost in peripheral vascular disease--platelet function and clinical outcome.
Fitscha P; Tiso B; Sinzinger H
Prog Clin Biol Res; 1987; 242():463-8. PubMed ID: 2444993
[No Abstract] [Full Text] [Related]
4. Current perspectives on venous disease.
Myers DD
Expert Rev Cardiovasc Ther; 2012 Jul; 10(7):839-41. PubMed ID: 22908916
[TBL] [Abstract][Full Text] [Related]
5. AHA/ACC guidelines for secondary prevention for patients with coronary and other atherosclerotic vascular disease: 2006 update endorsed by the National Heart, Lung, and Blood Institute.
; ; ; Smith SC; Allen J; Blair SN; Bonow RO; Brass LM; Fonarow GC; Grundy SM; Hiratzka L; Jones D; Krumholz HM; Mosca L; Pearson T; Pfeffer MA; Taubert KA
J Am Coll Cardiol; 2006 May; 47(10):2130-9. PubMed ID: 16697342
[No Abstract] [Full Text] [Related]
6. Comparison of the efficacy and safety of pharmacological treatment versus percutaneous coronary angioplasty in patients with intermediate coronary artery lesions.
Latacz P; Rostoff P; Gackowski A; El-Massri N; Konduracka E; Gajos G; Matysek J; Piwowarska W; Zmudka K
Kardiol Pol; 2009 Aug; 67(8A):1004-12. PubMed ID: 19784905
[TBL] [Abstract][Full Text] [Related]
7. [The treatment of vascular disorders in Alzheimer's disease].
Damulin IV
Zh Nevrol Psikhiatr Im S S Korsakova; 2005; 105(12):49-54. PubMed ID: 16447568
[No Abstract] [Full Text] [Related]
8. [Current treatment of systemic sclerosis. Part II. Vascular and antifibrotic treatment].
Sicińska J; Rudnicka L
Pol Merkur Lekarski; 2008 Aug; 25(146):196-200. PubMed ID: 18942347
[TBL] [Abstract][Full Text] [Related]
9. Cardiovascular and Hematological Medicine in 2015--Advances and Insights.
Mukherjee D
Cardiovasc Hematol Agents Med Chem; 2015; 13(1):1. PubMed ID: 26468555
[No Abstract] [Full Text] [Related]
10. Cardiovascular and Hematological Medicine in 2019 - Advances and Insights.
Mukherjee D
Cardiovasc Hematol Agents Med Chem; 2019; 17(1):2. PubMed ID: 31556359
[No Abstract] [Full Text] [Related]
11. Plaque biology: interesting science or pharmacological treasure trove?
Loftus I; Thompson M
Eur J Vasc Endovasc Surg; 2008 Nov; 36(5):507-16. PubMed ID: 18625571
[TBL] [Abstract][Full Text] [Related]
12. Measuring quality of outpatient cardiovascular care.
Koelling TM; Eagle KA
J Am Coll Cardiol; 2003 Jan; 41(1):69-72. PubMed ID: 12570947
[No Abstract] [Full Text] [Related]
13. Adjunct therapy in STEMI intervention.
Mehta S; Alfonso CE; Oliveros E; Shamshad F; Flores AI; Cohen S; Falcão E
Cardiol Clin; 2010 Feb; 28(1):107-25. PubMed ID: 19962053
[TBL] [Abstract][Full Text] [Related]
14. The role of miR-145 in microvasculature.
Ji LY; Jiang DQ; Dong NN
Pharmazie; 2013 Jun; 68(6):387-91. PubMed ID: 23875242
[TBL] [Abstract][Full Text] [Related]
15. [Internal treatment of chronic venous insufficiency. Clinico-pharmacological studies].
Tronnier H
Munch Med Wochenschr; 1968 Oct; 110(40):2303-7. PubMed ID: 4998528
[No Abstract] [Full Text] [Related]
16. Sulodexide in the treatment of chronic venous disease.
Andreozzi GM
Am J Cardiovasc Drugs; 2012 Apr; 12(2):73-81. PubMed ID: 22329592
[TBL] [Abstract][Full Text] [Related]
17. How optimal is the medical management of patients prior to major reconstructive vascular surgery? The results of a cross-sectional study.
Marshall C; Lin PH; Huynh TT; Kougias P
Vasc Endovascular Surg; 2009; 43(3):238-43. PubMed ID: 19190039
[TBL] [Abstract][Full Text] [Related]
18. Therapeutic use of n-3 fatty acids for vascular disease and thrombosis.
Goodnight SH; Cairns JA
Chest; 1995 Oct; 108(4 Suppl):302S-304S. PubMed ID: 7555184
[No Abstract] [Full Text] [Related]
19. Use of Albumin Solution in Patients Undergoing Cardiac Surgery With Cardiopulmonary Bypass.
Zhou Y; Zhu T; Chen C
JAMA; 2022 Nov; 328(20):2067. PubMed ID: 36413242
[No Abstract] [Full Text] [Related]
20. Uninsured South Florida vascular surgery patients are less likely to receive optimal medical management than their insured counterparts.
Yeh D; Jones M; Schulman C; Karmacharya J; Velazquez OC
J Vasc Surg; 2010 Apr; 51(4 Suppl):4S-8S. PubMed ID: 20346337
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
